| Theme | Optimal Sedation in Gastrointestinal Endoscopy : Understanding and Using the New Guidelines Correctly | |
|---|---|---|
| Title | Sedation During Therapeutic Procedures for Pancreaticobiliary Diseases | |
| Publish Date | 2015/05 | |
| Author | Koji Uno | Department of Gastroenterology, Kyoto Second Red Cross Hospital |
| Author | Kojiro Nakase | Department of Gastroenterology, Kyoto Second Red Cross Hospital |
| Author | Kenjiro Yasuda | Department of Gastroenterology, Kyoto Second Red Cross Hospital |
| [ Summary ] | Therapeutic procedures for pancreaticobiliary diseases are invasive and take a relatively long time. In these procedures, sedation is essential to improve patient satisfaction and procedure success rates. Sedatives such as midazolam and/or analgesics such as pethidine hydrochloride are administrated for sedation during endoscopic procedures. Recently, the intravenous anesthetic propofol has also started to be administered for sedation in some cases. Respiratory and hemodynamic adverse events may occur during endoscopic procedures under sedation. Therefore, it is necessary to evaluate the patient's condition and obtain the patient's informed consent prior to conducting the procedure. During the procedure, medical staff other than operator should observe the patient using cardiopulmonary monitoring in order to prevent the occurrence of some of the adverse events. Following the procedure, it is necessary to continue patient observation due to the potential occurrence of recurrent sedative effects. |
|